Rhythm Pharmaceuticals (RYTM) PT Raised to $129 at Morgan Stanley
Tweet
Share
E-mailGet Alerts RYTM Hot Sheet
Price: $84.71 +0.43%
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Morgan Stanley analyst Jeffrey Hung raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $129.00 (from $122.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Nitto Denko (6988:JP) (NDEKY) PT Lowered to JPY3,400 at Nomura/Instinet
- Nomura/Instinet Downgrades T&D Holdings Inc (8795:JP) (TDHOY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
